Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glycoprotein 130 (gp130) is a type I transmembrane protein that serves as the common signal-transducing receptor subunit for the interleukin-6 (IL-6) family of cytokines. It plays a central role in mediating cellular responses to various cytokines, activating downstream pathways like JAK/STAT, PI3K/Akt, and MAPK/ERK. gp130-mediated signaling is essential for inflammatory responses, immune system regulation, hematopoiesis, and cardiac function. Disruption or dysregulation can contribute to diseases such as autoimmune disorders and cancers.
Modulation of downstream signaling pathways (JAK/STAT, PI3K/Akt, MAPK/ERK) through ligand binding and receptor dimerization/oligomerization.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycoprotein 130 (gp130).